Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs

NYT HEALTH: Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs
By Christina Jewett
Section: Health
Source: New York Times
Published Date: April 15, 2024 at 03:00AM

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.

Read more: https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html?partner=IFTTT